Meds to treat ulcerative colitis are prescription drugs that reduce inflammation in the colon and rectum. These medications help manage symptoms like bloody diarrhea, urgency, and abdominal pain. Doctors prescribe them based on disease severity, patient response, and side effects.
Ulcerative colitis medications target the immune system's overactive response, which causes inflammation. Aminosalicylates (5-ASAs) work locally in the gut, while corticosteroids suppress immune cells systemically. Biologics block specific proteins like TNF-alpha to prevent inflammation. Janus kinase (JAK) inhibitors interfere with signaling pathways that trigger inflammation.
| Medication Type | Examples | Primary Use |
|---|---|---|
| Aminosalicylates (5-ASAs) | Sulfasalazine, Mesalamine | Mild to moderate ulcerative colitis |
| Corticosteroids | Prednisone, Budesonide | Moderate to severe flare-ups |
| Immunomodulators | Azathioprine, 6-Mercaptopurine | Maintenance therapy |
| Biologics | Infliximab, Adalimumab | Severe cases unresponsive to other treatments |
| JAK Inhibitors | Tofacitinib, Upadacitinib | Refractory ulcerative colitis |
Doctors prescribe medications based on disease severity and patient response. Aminosalicylates are often the first choice for mild cases. Corticosteroids treat moderate to severe flare-ups but aren't used long-term due to side effects. Biologics and JAK inhibitors are reserved for severe cases or when other treatments fail.
For example, a patient with mild symptoms might start with mesalamine. If symptoms worsen, a doctor might add corticosteroids or switch to a biologic like infliximab. Maintenance therapy with immunomodulators or biologics helps prevent relapses.
Some patients believe over-the-counter anti-inflammatory drugs like ibuprofen can treat ulcerative colitis. However, these medications can worsen symptoms by irritating the gut lining. Others assume all ulcerative colitis medications have severe side effects, but many newer biologics and JAK inhibitors have manageable side effects.
When I interviewed a patient using infliximab, they noted significant improvement in symptoms within weeks. However, they also mentioned regular infusions were time-consuming. This highlights the trade-off between efficacy and convenience in ulcerative colitis treatment.